The Houston Astros had a slow start in 2024 but rebounded well to win their division. However, they flamed out in the postseason, as they were swept at home by the Detroit Tigers. They could now ...

The Chicago Bears have a crucial offseason ahead of them. They not only have to find a new head coach but also have to surround Caleb Williams with great players. The Bears acquired D.J. Moore ...

And it's the most meaningful one yet. This weekend, the animated blockbuster became the third film of 2024 to pass the coveted $1 billion mark at the worldwide box office. Moana 2 is only the ...

The San Francisco Giants have sought a superstar hitter ever since their current president of baseball operations, Buster Posey, began exiting his prime. A solution could be peeking over the horizon.

The Boston Celtics aren't expected to be very active ahead of the NBA trade deadline and for good reason. Boston is one of the best teams in the NBA this season and they have a solid core in place.

They could strike one more blockbuster trade before opening day. Fireside Yankees of Empire Sports Media suggested this trade package that would bring Carlos Correa from the Minnesota Twins to the ...

The Los Angeles Angels could add a high-priced All-Star slugger in a blockbuster move this winter. With spring training nearly a month away, the New York Mets and free agent first baseman Pete ...

Tech companies could spend a record amount of money building artificial intelligence (AI) data centers this year. Suppliers of chips and other hardware components could be big beneficiaries of ...

According to Morgan Stanley, a group of four tech giants (Microsoft, Amazon, Alphabet, and Meta Platforms) could spend a combined $300 billion building data center infrastructure for artificial ...

But the Japanese giant is keeping players waiting for full details of the successor model, showing off the console's appearance in a slick video Thursday but delaying any detailed information ...

This year's reconstituted Golden State Warriors look almost exactly like the 2023-24 model, right down to occupying the No. 10 seed in the Western Conference (so far, anyway). Despite 10-time All ...

Johnson & Johnson’s seltorexant is one of two new therapies that the company reckons could become blockbuster treatments for depression, and data from a phase 3 trial keeps that hope alive.